Datametrex Announces Sale of COVID-19 Test Kits to Canadian Royalties
June 09 2020 - 1:30PM
Datametrex AI Limited (the
“
Company” or “
Datametrex”)
(
TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to
announce that it has received a purchase order (the
“PO”) for COVID-19 test kits from Canadian
Royalties Inc. (“CRI”), a Quebec based mining company.
Under the terms of the PO, Datametrex will sell
to the purchaser an intial 2,000 units of Health Canada authorized
COVID-19 qPCR Detection Kits manufactured by 1drop Inc. and 2,000 3
mL Univesal Transport Medium (UTM®) Sterile Swabs with 16x100mm
Skirted Tubes with testing being conducted by Transpharm Canada
Inc. (“TCI”). The Company has secured all testing
kits from the manufacturer required to fulfill the order. All of
the items will be shipped directly from manufacturer to the TCI
lab. Datametrex anticipates that it will have little or no upfront
costs associated with the sale of these test kits.
“It has been a pleasure working with the team at
Canadian Royalties, their commitment to keeping their operations
open in a responsible and safe manner is truly representative of
the Canadian spirit we are proud to be part of,” said Marshall
Gunter, CEO of the Company.
Datametrex’s mission is to provide tools that
support companies in fulfilling their operational Health and Safety
goals with predictive and preventive technologies. By working with
companies to set a new standard of protocols through Artificial
Intelligence and health diagnostics, the Company provides
progressive solutions to support the supply chain.
About Canadian Royalties
Canadian Royalties Inc. ("CRI") is a private
mining company based in Montreal that operates a copper and nickel
mine in Nunavik (province of Quebec), under the name Nunavik Nickel
Project ("Project"). The production phase started in February 2013,
with a concentrator of a capacity of 4,500 tons/day, fed by various
mines, including EXPO, ALLAMMAQ and MEQUILLON. CRI’s nickel and
copper concentrates are trucked and stored daily at our Deception
Bay port facilities, about 120 km from the main EXPO camp. An
ice-breaker vessel named "Nunavik", comes to Deception roughly
seven times a year, bringing operational material from overseas and
pick up concentrate to deliver to Europe. CRI allows more than
1,000 people to work on its facilities for the operations,
including 600 direct employees and 400 subcontractors. It is an
average of 400 people who live and work on constant rotation on the
Project, whether at EXPO camp or Deception Bay camp, all on a
fly-in / fly-out rotation. We also have about thirty employees
based at our Montreal corporate offices. Additional information on
CRI is available at www.canadianroyalties.com
About Transpharm Canada
Inc.
Transpharm Canada Inc. provides pharmaceutical
education, technology, and research opportunities to students
through its subsidiary, Toronto Institute of Pharmaceutical
Technology, North America's premier pharmaceutical training
institute. The facility is also fully compliant Health Canada
licensed Good Manufacturing Practice (“GMP”) manufacturing and
testing facility and is a full-service clinical development
business that provides clinical trial services to biotechnology
companies. Additional information on TIPT is available
at www.tipt.com
About 1drop Inc.
1drop Inc. aims to provide a solution to manage
health with a drop of fluid. It has the key technologies for
becoming a global leading company in the field of smart health
care. 1copy™ COVID-19 qPCR Multi Kit can reduce the risk of
asymptomatic and latent infection of COVID-19 by a single virus
level limit of detection. Additional information on 1drop Inc. is
available at www.1drop.co.kr
About Datametrex
Datametrex AI Limited is a technology focused
company with exposure to Artificial Intelligence and Machine
Learning through its wholly owned subsidiary, Nexalogy
(www.nexalogy.com). Datametrex’s mission is to provide tools that
support companies in fulfilling their operational goals, including
Health and Safety, with predictive and preventive technologies. By
working with companies to set a new standard of protocols through
Artificial Intelligence and health diagnostics, the Company
provides progressive solutions to support the supply chain.
Additional information on Datametrex is available at
www.datametrex.com.
For further information, please
contact:
Marshall Gunter – CEOPhone: (514) 295-2300Email:
mgunter@datametrex.com
Neither the TSX Venture Exchange nor it's
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking
information” within the meaning of applicable securities
laws. All statements contained herein that are not clearly
historical in nature may constitute forward-looking information. In
some cases, forward-looking information can be identified by words
or phrases such as “may”, “will”, “expect”, “likely”, “should”,
“would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”,
“estimate”, “believe” or the negative of these terms, or other
similar words, expressions and grammatical variations thereof, or
statements that certain events or conditions “may” or “will”
happen, or by discussions of strategy.Readers are cautioned to
consider these and other factors, uncertainties and potential
events carefully and not to put undue reliance on forward-looking
information. The forward-looking information contained herein is
made as of the date of this press release and is based on the
beliefs, estimates, expectations and opinions of management on the
date such forward-looking information is made. The Company
undertakes no obligation to update or revise any forward-looking
information, whether as a result of new information, estimates or
opinions, future events or results or otherwise or to explain any
material difference between subsequent actual events and such
forward-looking information, except as required by applicable
law.
DataMetrex AI (TSXV:DM)
Historical Stock Chart
From Mar 2024 to Apr 2024
DataMetrex AI (TSXV:DM)
Historical Stock Chart
From Apr 2023 to Apr 2024